O36.11
Maternal care for Anti-A sensitization
Clinical Classification Guidelines
Inclusion Terms
- Maternal care for isoimmunization NOS (with hydrops fetalis)
Medical Intelligence & Overview
Maternal care for Anti-A sensitization involves managing pregnancies where the mother’s immune system has developed antibodies against fetal red blood cell antigens, specifically anti-A antibodies. This condition, known as isoimmunization, can lead to serious fetal complications such as hemolytic disease and hydrops fetalis. Proper monitoring and intervention are crucial to protect the health of both mother and baby throughout pregnancy.
Causes & Symptoms
Clinical Causes: Previous pregnancies with incompatible blood types Blood transfusions involving incompatible blood Miscarriage or abortion procedures with incompatible blood exposure Maternal blood type incompatible with fetal blood type, especially in ABO incompatibility (mother type O, fetus type A or B)
Key Symptoms: Fetal anemia detected through ultrasound Hydrops fetalis, characterized by abnormal accumulation of fluid in fetal tissues and cavities Signs of fetal distress during pregnancy, such as increased heart rate In severe cases, signs of fetal heart failure or death
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves several approaches to assess the presence and effects of anti-A antibodies and fetal health status:
Treatment Protocols: Management aims to minimize fetal risk through close monitoring and interventions as needed:
Clinical Advice & FAQs
Billing Guidance
Is O36.11 a billable ICD-10 code?
Yes, O36.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.11?
Clinical documentation must specify the nature of Maternal care for Anti-A sensitization and any associated comorbidities for accurate reporting.
Cite this Clinical Reference